Search for a trial

A randomized, parallel-group clinical pharmacology study to assess the pharmacokinetics and pharmacodynamics of Tysabri® in healthy volunteers

The purpose of this study is to investigate how quickly and to what extent different doses of EU­approved Tysabri® are absorbed and eliminated from the body (this is called pharmacokinetics) and how the body responds to different doses of Tysabri (…

A Phase 1/2 Randomized, Blinded, Dose-escalation Study to Evaluate the Safety and Efficacy of Intrathecal Administration of AAV9-ABCD1 Gene Therapy (SBT101) in Adult Patients with Adrenomyeloneuropathy

This study has been transitioned to CTIS with ID 2024-518451-39-00 check the CTIS register for the current data. • To characterize the safety and tolerability of one-time IT administered SBT101 in adults diagnosed with AMN.• To characterize the…